PURPOSE: We compared the effects of consumption of n-3 polyunsaturated fatty acids (PUFA)-enriched tomato juice versus plain tomato juice on the serum lipid profile and levels of biomarkers related to antioxidant status and cardiovascular disease (CVD) risk in women. METHODS:Eighteen healthy women participated in a 2-week intervention trial involving the daily intake of 500 mL of n-3 PUFA-enriched juice (n = 11) or plain tomato juice (n = 7). Each serving of enriched juice provided 250 mg of eicosapentaenoic acid (EPA) plus docosahexanoic acid (DHA). Both juices provided natural antioxidant compounds such as phenolics (181 mg) and lycopene (26.5 mg). RESULTS: Intervention with the enriched juice had no effect on the lipid profile, and serum levels of triglycerides and cholesterol (total, LDL, and HDL) remained unchanged. The serum antioxidant status improved following juice intake, as revealed by an increase in total antioxidant capacity and a slight decrease in lipid peroxidation. The serum levels of homocysteine, a cardiovascular risk factor, decreased following n-3 PUFA-enriched juice consumption. A decrease in vascular adhesion molecule 1 (VCAM-1) levels was also noted after intake of either plain or enriched tomato juice, whereas intercellular adhesion molecule 1 (ICAM-1) levels only decreased following intake of the enriched juice. CONCLUSIONS: Overall, stronger positive amelioration of CVD risk factors was observed following the intake of n-3 PUFA-enriched juice than after plain tomato juice consumption, which suggested a possible synergistic action between n-3 PUFAs and tomato antioxidants.
RCT Entities:
PURPOSE: We compared the effects of consumption of n-3 polyunsaturated fatty acids (PUFA)-enriched tomatojuice versus plain tomatojuice on the serum lipid profile and levels of biomarkers related to antioxidant status and cardiovascular disease (CVD) risk in women. METHODS: Eighteen healthy women participated in a 2-week intervention trial involving the daily intake of 500 mL of n-3 PUFA-enriched juice (n = 11) or plain tomatojuice (n = 7). Each serving of enriched juice provided 250 mg of eicosapentaenoic acid (EPA) plus docosahexanoic acid (DHA). Both juices provided natural antioxidant compounds such as phenolics (181 mg) and lycopene (26.5 mg). RESULTS: Intervention with the enriched juice had no effect on the lipid profile, and serum levels of triglycerides and cholesterol (total, LDL, and HDL) remained unchanged. The serum antioxidant status improved following juice intake, as revealed by an increase in total antioxidant capacity and a slight decrease in lipid peroxidation. The serum levels of homocysteine, a cardiovascular risk factor, decreased following n-3 PUFA-enriched juice consumption. A decrease in vascular adhesion molecule 1 (VCAM-1) levels was also noted after intake of either plain or enriched tomatojuice, whereas intercellular adhesion molecule 1 (ICAM-1) levels only decreased following intake of the enriched juice. CONCLUSIONS: Overall, stronger positive amelioration of CVD risk factors was observed following the intake of n-3 PUFA-enriched juice than after plain tomatojuice consumption, which suggested a possible synergistic action between n-3 PUFAs and tomato antioxidants.
Authors: Earl S Ford; S Jay Smith; Donna F Stroup; Karen K Steinberg; Patricia W Mueller; Stephen B Thacker Journal: Int J Epidemiol Date: 2002-02 Impact factor: 7.196
Authors: J M Wallace; A J McCabe; P J Robson; M K Keogh; C A Murray; P M Kelly; G Márquez-Ruiz; H McGlynn; W S Gilmore; J J Strain Journal: Ann Nutr Metab Date: 2000 Impact factor: 3.374
Authors: Michael A Leslie; Daniel J A Cohen; Danyelle M Liddle; Lindsay E Robinson; David W L Ma Journal: Lipids Health Dis Date: 2015-06-06 Impact factor: 3.876
Authors: Roel J T Mocking; Johanna Assies; Mariska Bot; Eugene H J M Jansen; Aart H Schene; François Pouwer Journal: PLoS One Date: 2012-11-28 Impact factor: 3.240
Authors: Daniel Cuevas-Ramos; Paloma Almeda-Valdés; Emma Chávez-Manzanera; Clara Elena Meza-Arana; Griselda Brito-Córdova; Roopa Mehta; Oscar Pérez-Méndez; Francisco J Gómez-Pérez Journal: Diabetes Metab Syndr Obes Date: 2013-07-26 Impact factor: 3.168